Study details
Enrolling now
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
VA Office of Research and Development
NCT IDNCT05486572ClinicalTrials.gov data as of Apr 2026
Target enrollment
4,700
Study length
about 7.8 years
Ages
18–75
Locations
17 sites in CA, CO, CT +10
What this study is about
This trial is testing whether an abbreviated MRI screening with blood tests, or abdominal ultrasound screening with blood tests, can help detect liver cancer earlier in people with cirrhosis. The goal is to see if this approach leads to a reduction in deaths from liver cancer.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Abbreviated Magnetic Resonance Imaging with serum AFP
- 2.Undergo Abdominal Ultrasound Screening with serum AFP
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Overall Survival
Body systems
Gastroenterology